Fabrizio Valleggi
Overview
Explore the profile of Fabrizio Valleggi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gennari L, Merlotti D, Valleggi F, Nuti R
Expert Opin Investig Drugs
. 2009 May;
18(6):839-49.
PMID: 19466874
Background: Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact with intracellular estrogen receptors in target organs as estrogen agonists and antagonists. These drugs have been intensively studied...
2.
Martini G, Gennari L, de Paola V, Pilli T, Salvadori S, Merlotti D, et al.
Thyroid
. 2008 Apr;
18(4):455-60.
PMID: 18399769
Objective: Recently it was found that thyrotropin (TSH) receptors are present both in osteoclast and osteoblast and that TSH can modulate bone remodeling independent of thyroid hormones. The aim of...
3.
Merlotti D, Gennari L, Martini G, Valleggi F, de Paola V, Avanzati A, et al.
J Bone Miner Res
. 2007 Jul;
22(10):1510-7.
PMID: 17605632
Unlabelled: This randomized study compared different intravenous bisphosphonates in PDB. Zoledronate was superior with respect to pamidronate in achieving biochemical remission, with therapeutic response maintained in most patients at 15...
4.
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development
Gennari L, Merlotti D, Valleggi F, Martini G, Nuti R
Drugs Aging
. 2007 May;
24(5):361-79.
PMID: 17503894
Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact with intracellular estrogen receptors in target organs as estrogen receptor agonists and antagonists. These drugs have been intensively studied...